K-numberK251350
Device nameBD Plastipak™ Syringe
ApplicantBecton, Dickinson and Company
Product codeFMF
Device classClass II
Decision dateJul 29, 2025
DecisionSubstantially Equivalent
Regulation880.5860
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The BD Plastipak™ Syringe is a three-piece, single-use, sterile hypodermic syringe with a 6% (Luer) male connector available in 20 mL and 50 mL eccentric luer slip tip configurations. It is intended for use by healthcare professionals for general purpose fluid aspiration and injection, with components including a polypropylene barrel, synthetic rubber stopper, and polypropylene plunger rod, sterilized by ethylene oxide gas.

Technological characteristics

The subject device differs from the predicate (BD Single Use, Hypodermic Syringe) primarily in barrel resin material and supplier: the subject uses polypropylene (HPR35CMD) versus the predicate's polypropylene (PH-712B). The subject is available only in 20 mL and 50 mL luer-slip eccentric tip configurations, whereas the predicate offers 1–50 mL in multiple tip configurations (luer-lok, luer-slip, eccentric). All other components, sterilization method, shelf life, and packaging are identical between devices.

Test standards cited

ISO 7886-1:2017 (breakout force, sustaining force, leakage past stopper, volumetric accuracy, dead space); ISO 80369-7:2021 (luer leakage, stress cracking, resistance to axial separation); ISO 10993-5:2009, 10993-10:2021, 10993-23:2021, 10993-11:2017, 10993-4:2017 (biocompatibility); ASTM F756-17 (hemolytic properties); USP43-NF38 <151> (pyrogen test).

Substantial equivalence argument

The change in barrel resin material and supplier does not alter the device's intended use, operating principle (piston syringe), or performance characteristics. The subject device's 20 mL and 50 mL sizes fall within the predicate's range of available sizes. Comprehensive bench performance testing (force, leakage, accuracy, luer integrity) and biocompatibility testing (cytotoxicity, sensitization, systemic toxicity, hemocompatibility) all met predetermined acceptance criteria, demonstrating no new questions or modified risks of safety and effectiveness.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →